JAMIE HOLZ: Open Payments
NPI 1912565995 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 13 payments from 5 companies in 2025. Trend: 2023 $605 · 2024 $995 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $148 |
| Alkermes, Inc. | 3 | $142 |
| Neurocrine BioSciences, Inc. | 2 | $141 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 1 | $30 |
Products named: INGREZZA, OPDIVO, LYBALVI, COBENFY, ABILIFY ASIMTUFII, Qelbree, ARISTADA, VIVITROL.
Industry payments across OK — which companies pay providers there.
